share_log

Biora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer NEUMANN CLARKE

SEC announcement ·  Feb 15 16:09
Summary by Moomoo AI
Clarke Neumann, associated with Biora Therapeutics, Inc. (BIOR), was granted 230,000 shares of common stock on February 15, 2024. The transaction was classified as a grant, indicating an award or acquisition rather than a purchase, and was carried out at no cost to Neumann. Following this transaction, Neumann's direct holdings in Biora Therapeutics increased to a total of 492,193 shares. The grant is part of an ongoing transaction, with the details reported as per regulatory requirements.
Clarke Neumann, associated with Biora Therapeutics, Inc. (BIOR), was granted 230,000 shares of common stock on February 15, 2024. The transaction was classified as a grant, indicating an award or acquisition rather than a purchase, and was carried out at no cost to Neumann. Following this transaction, Neumann's direct holdings in Biora Therapeutics increased to a total of 492,193 shares. The grant is part of an ongoing transaction, with the details reported as per regulatory requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more